LLY

908.52

+0.64%↑

UNH

593.89

-0.49%↓

NVO

131.93

+0.67%↑

JNJ

166.62

+1.37%↑

ABBV

196.25

+1.59%↑

LLY

908.52

+0.64%↑

UNH

593.89

-0.49%↓

NVO

131.93

+0.67%↑

JNJ

166.62

+1.37%↑

ABBV

196.25

+1.59%↑

LLY

908.52

+0.64%↑

UNH

593.89

-0.49%↓

NVO

131.93

+0.67%↑

JNJ

166.62

+1.37%↑

ABBV

196.25

+1.59%↑

LLY

908.52

+0.64%↑

UNH

593.89

-0.49%↓

NVO

131.93

+0.67%↑

JNJ

166.62

+1.37%↑

ABBV

196.25

+1.59%↑

LLY

908.52

+0.64%↑

UNH

593.89

-0.49%↓

NVO

131.93

+0.67%↑

JNJ

166.62

+1.37%↑

ABBV

196.25

+1.59%↑

Inicio・Lista de Acciones・Accuray Inc

Accuray Inc

Abierto

Sector Salud

1.98 3.12

Comprar Vender

Resumen

Variación precio

24h

Actual

Mínimo

1.88

Máximo

Métricas clave
By Trading Economics
Ingresos	-3M
Ventas	3.3M 107M
BPA	-0.1
Margen de beneficio	-2.858
EBITDA	3.5M

Recomendaciones
By TipRanks
Recomendaciones	Compra Fuerte
Estimación a 12 meses	+229.69 upside

Dividendos
By Dow Jones
Próximas Ganancias	5 nov 2024

Estadísticas de Mercado
By TradingEconomics
Capitalización de Mercado	1M 239M
Apertura anterior	-1.14
Cierre anterior	1.98

Noticias sobre sentimiento de mercado

By Acuity

13%

87%

14 / 365 Clasificación en Healthcare

Puntuación técnica

By Trading Central

Confianza

Strong Bearish Evidence

N/A / 2.11 Soporte y Resistencia

Accuray Inc Gráfico

El rendimiento pasado no es un indicador fiable de resultados futuros.

Noticias Relacionadas

8 sept 2024, 23:42 UTC

Ganancias

Syrah Resources: Vidalia AAM Facility Has Ramped Up Operations

8 sept 2024, 23:41 UTC

Ganancias

Syrah Resources: No Natural Graphite Shipments in Half-Year to Chinese Anode Customers Amid Competition, Oversupply

8 sept 2024, 23:40 UTC

Ganancias

Syrah Resources: Half-Year Balama Production and Sales Decreased Compared With Prior Period

8 sept 2024, 23:37 UTC

Ganancias

Syrah Resources: Half-Year Revenue US$19 Mln Vs US$28.4 Mln in Prior Period

8 sept 2024, 23:37 UTC

Ganancias

Syrah Resources: Half-Year Comprehensive Loss US$63.3 Mln Vs US$37.1 Mln Loss in Prior Period

8 sept 2024, 22:38 UTC

Principales Noticias

Stocks Are Poised to Fall -- Barrons.com

8 sept 2024, 18:40 UTC

Principales Noticias

Elon Musk's xAI Has Discussed Deal for Share in Future Tesla Revenue, Sources Say -- Update

8 sept 2024, 15:24 UTC

Principales Noticias

Boeing Reaches Deal With Biggest Union in Effort to Avoid Strike -- WSJ

8 sept 2024, 13:00 UTC

Principales Noticias

Crypto Plan Creates Potential Conflicts for Trump -- WSJ

8 sept 2024, 09:00 UTC

Principales Noticias

Nvidia Draws Antitrust Scrutiny as Enforcers Signal Early Interest in AI -- WSJ

8 sept 2024, 07:30 UTC

Principales Noticias

Biotechs Are in Focus as Congress Looks to Get Tougher on China -- Barrons.com

8 sept 2024, 01:00 UTC

Principales Noticias

Elon Musk's xAI Has Discussed Deal for Share in Future Tesla Revenue, Sources Say -- WSJ

7 sept 2024, 17:35 UTC

Principales Noticias

Fed Outlook Remains Uncertain After September Cut -- Barrons.com

7 sept 2024, 09:30 UTC

Principales Noticias

Jobs Slowdown Frustrates Investors Who Wanted Certainty on the Fed -- Heard on the Street -- WSJ

7 sept 2024, 08:20 UTC

Charlas de Mercado

Financial Services Roundup: Market Talk

7 sept 2024, 04:05 UTC

Principales Noticias

China's Forex Reserves Rose in August as U.S. Dollar Weakened -- WSJ

6 sept 2024, 22:41 UTC

Charlas de Mercado

KinderCare and StandardAero File for IPOs -- Market Talk

6 sept 2024, 21:18 UTC

Principales Noticias

Hiring Softened This Summer, Teeing Up Fed Rate Cuts -- Update

6 sept 2024, 21:05 UTC

Principales Noticias

U.S. Tells Allies Iran Has Sent Ballistic Missiles to Russia, European and U.S. Officials Say -- 4th Update

6 sept 2024, 20:50 UTC

Charlas de Mercado

Auto & Transport Roundup: Market Talk

6 sept 2024, 20:39 UTC

Ganancias

Update: NIO Stock Caught an Upgrade. Shares Rose. -- Barrons.com

6 sept 2024, 20:35 UTC

Principales Noticias

Stocks Extend Ugly Week of Losses Amid Economic Uncertainty -- WSJ

6 sept 2024, 20:34 UTC

Principales Noticias

U.S. Tells Allies Iran Has Sent Ballistic Missiles to Russia, European and U.S. Officials Say -- 3rd Update

6 sept 2024, 20:11 UTC

Principales Noticias

Stock Indexes Close Lower After Mixed Jobs Report -- WSJ

6 sept 2024, 19:51 UTC

Principales Noticias

U.S. Tells Allies Iran Has Sent Ballistic Missiles to Russia, European and U.S. Officials Say -- WSJ

6 sept 2024, 19:16 UTC

Charlas de Mercado

U.S. Natural Gas Futures Hold Gains -- Market Talk

6 sept 2024, 19:14 UTC

Charlas de Mercado

Oil Futures Extend Losses on Demand Concerns -- Market Talk

6 sept 2024, 19:01 UTC

Charlas de Mercado

Gold Slips on Prevailing Uncertainty -- Market Talk

6 sept 2024, 18:27 UTC

Principales Noticias

JPMorgan Plans to Report Customers Who Exploited TikTok 'Glitch' to Authorities -- WSJ

6 sept 2024, 18:25 UTC

Charlas de Mercado

Broadcom Growth Views Conservative Amid AI Investments -- Market Talk

Comparación entre iguales

Cambio de precio

Accuray Inc Esperado

Precio Objetivo

By TipRanks

229.69% repunte

Estimación a 12 meses

Media 6.33 USD 229.69%

Máximo 7 USD

Mínimo 6 USD

De acuerdo con 3 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para Accuray Inc Dist en los últimos 3 meses.

Consenso

By TipRanks

Compra Fuerte

3 ratings

Comprar

Mantener

Vender

De acuerdo con 3 analistas que ofrecen calificaciones bursátiles a para Accuray Inc Dist en los últimos 3 meses.

Puntuación técnica

By Trading Central

N/A / 2.11Soporte y Resistencia

Recent bearish events outweigh bullish events.

All events are bullish.

All events are bearish.

Sentimiento

By Acuity

14 / 365 Clasificación en Salud

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

Acerca de Accuray Inc

Accuray Incorporated is a radiation therapy company. The Company develops, manufactures, sells and supports market-changing solutions that are designed to deliver radiation treatments. The Company's technologies include the CyberKnife and TomoTherapy platforms, including the Radixact System. The CyberKnife and TomoTherapy platform, which are designed to deliver treatments, including stereotactic radiosurgery (SRS), stereotactic body radiation therapy (SBRT), intensity modulated radiation therapy (IMRT), image-guided radiation therapy (IGRT) and adaptive radiation therapy (ART). The CyberKnife Systems are robotic systems that are used to treat various types of cancer and tumors throughout the body. The CyberKnife Systems track, detect and correct for tumor and patient movement in real-time during the procedure. The TomoTherapy Systems include the TomoTherapy H Series with configuration options of TomoH, TomoHD and TomoHDA.